FR2308368A1 - Sel soluble de la cephalexine comme antibiotique injectable - Google Patents
Sel soluble de la cephalexine comme antibiotique injectableInfo
- Publication number
- FR2308368A1 FR2308368A1 FR7512916A FR7512916A FR2308368A1 FR 2308368 A1 FR2308368 A1 FR 2308368A1 FR 7512916 A FR7512916 A FR 7512916A FR 7512916 A FR7512916 A FR 7512916A FR 2308368 A1 FR2308368 A1 FR 2308368A1
- Authority
- FR
- France
- Prior art keywords
- well
- cephalexin
- orally
- infections
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940106164 cephalexin Drugs 0.000 title abstract 4
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 title abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 241000700198 Cavia Species 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 206010067268 Post procedural infection Diseases 0.000 abstract 1
- 241000700159 Rattus Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000008485 antagonism Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 abstract 1
- 229960003866 cefaloridine Drugs 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000010255 intramuscular injection Methods 0.000 abstract 1
- 238000010253 intravenous injection Methods 0.000 abstract 1
- 239000012454 non-polar solvent Substances 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 230000000630 rising effect Effects 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 210000001635 urinary tract Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7512916A FR2308368A1 (fr) | 1975-04-21 | 1975-04-21 | Sel soluble de la cephalexine comme antibiotique injectable |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7512916A FR2308368A1 (fr) | 1975-04-21 | 1975-04-21 | Sel soluble de la cephalexine comme antibiotique injectable |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2308368A1 true FR2308368A1 (fr) | 1976-11-19 |
| FR2308368B1 FR2308368B1 (enrdf_load_stackoverflow) | 1979-03-09 |
Family
ID=9154463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7512916A Granted FR2308368A1 (fr) | 1975-04-21 | 1975-04-21 | Sel soluble de la cephalexine comme antibiotique injectable |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2308368A1 (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6225304B1 (en) | 1999-02-17 | 2001-05-01 | Pharmaceutical Solutions, Inc. | Soluble forms of amoxicillin and treatment of animals |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2190422A1 (enrdf_load_stackoverflow) * | 1972-06-30 | 1974-02-01 | Takeda Chemical Industries Ltd | |
| FR2220533A1 (enrdf_load_stackoverflow) * | 1973-03-08 | 1974-10-04 | Gallardo Antonio Sa |
-
1975
- 1975-04-21 FR FR7512916A patent/FR2308368A1/fr active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2190422A1 (enrdf_load_stackoverflow) * | 1972-06-30 | 1974-02-01 | Takeda Chemical Industries Ltd | |
| FR2220533A1 (enrdf_load_stackoverflow) * | 1973-03-08 | 1974-10-04 | Gallardo Antonio Sa |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6225304B1 (en) | 1999-02-17 | 2001-05-01 | Pharmaceutical Solutions, Inc. | Soluble forms of amoxicillin and treatment of animals |
| US6492354B2 (en) | 1999-02-17 | 2002-12-10 | Pharmaceutical Solutions, Inc. | Soluble forms of amoxicillin and treatment of animals |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2308368B1 (enrdf_load_stackoverflow) | 1979-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY108541A (en) | Purine derivatives and use thereof in therapy. | |
| IE41374L (en) | Composition for treating schizophrenia | |
| NO830686L (no) | Fremgangsmaate for fremstilling av erytromycinderivater | |
| PT1102594E (pt) | Utilizacao de cloreto de sodio para reduzir a toxicidade gastrointestinal de derivados de camptotecina | |
| FR2308368A1 (fr) | Sel soluble de la cephalexine comme antibiotique injectable | |
| NZ233704A (en) | Dehydrocholecalciferol derivatives, pharmaceutical compositions thereof | |
| FR2318649A1 (fr) | Medicament pour le traitement des rhumatismes et cancers | |
| GB1319868A (en) | Antiviral medicines comprising rifamycin derivatives | |
| IL66473A0 (en) | Aminoglycoside derivatives,their production and pharmaceutical compositions containing them | |
| FR2252103A1 (en) | Hydroxamino-substd. oxazolobenzodiazepines - sedatives, muscle relaxants and anti-convulsants | |
| JPS52128232A (en) | Drugs for alleviating toxicity to kidneys | |
| JPS5527133A (en) | Drug comprising organosilicon compound as main constituent | |
| IE45096L (en) | Thiadiazole derivatives | |
| IL43609A (en) | Pharmaceutical mixtures contain salts of sulphoglycopeptides with amino acids | |
| JPS54151134A (en) | Antitumorigenic agent | |
| FR2320098A1 (fr) | Nouveaux derives de la thiazilo (3,4-b) isoquinoleine, leur preparation et les compositions qui les contiennent | |
| JPS5231051A (en) | Preparation of amino sugar derivatives | |
| GB1502727A (en) | Bicyclic derivatives of 7-acylamido-3-cephem-4-carboxylic acid and process for their preparation | |
| JPS5610114A (en) | Novel analgesic and anti-inflammatory agent | |
| GB1279547A (en) | N-arylidene derivatives of erythromycylamine | |
| JPS5219647A (en) | Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt | |
| FR2313923A1 (fr) | Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire | |
| FR2457869A1 (fr) | Derives de thieno(2',3'; 4,5) pyrido (1,2-a) pyrazine, leur procede de preparation et leur application therapeutique | |
| GB1461860A (en) | Semi-synthetic penicillin | |
| JPS5629600A (en) | Novel 2-fluoro-n6,o2'-diacyl-adenosine-3',5'-cyclic phosphate, its preparation, and carcinostatic agent containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| CD | Change of name or company name | ||
| ST | Notification of lapse |